Whilst it effectively improves glycaemic control and promotes weight loss, some patients have reported urinary symptoms during treatment
Recovery and Sleep Support CJC-1295 and Ipamorelin are frequently discussed for their potential role in exercise recovery, sleep quality and tissue repair through growth hormone signalling
Nutrients, 15 (16), 3634
To assess the associations of semaglutide with incident AUD (first time diagnosis of AUD), the study population included 83,825 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new-user design) prescribed semaglutide or non-GLP-1RA anti-obesity medications (naltrexone, topiramate, bupropion, orlistat, phentermine) 54 during 6/202112/2022 (time zero or index event), had no diagnosis of AUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
These medications can help suppress appetite, increase feelings of fullness, or inhibit the absorption of dietary fat